20 ACTUAT zanamivir 5 MG/ACTUAT Dry Powder Inhaler [Relenza]
RxNorm concept 759473, branded drug (sbd). Prescribable name: RELENZA DISKHALER 5 MG/INHAL Dry Powder Inhaler, 20 Blisters.
- RxCUI
- 759473
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/759473 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
20 ACTUAT Relenza 5 MG/ACTUAT Dry Powder Inhaler; Relenza 5 MG/ACTUAT Dry Powder Inhaler, 20 ACTUAT
Related concepts
- zanamivir 5 MG/ACTUAT (SCDC, consists of)
- zanamivir 5 MG/ACTUAT [Relenza] (SBDC, consists of)
- Dry Powder Inhaler (DF, has dose form)
- Relenza (BN, has ingredient)
- 20 ACTUAT zanamivir 5 MG/ACTUAT Dry Powder Inhaler (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 759473 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/759473 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 759473. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.